1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Neurological Diagnostic Equipment - Medical Devices Pipeline Assessment, 2016

Neurological Diagnostic Equipment - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Neurological Diagnostic Equipment - Medical Devices Pipeline Assessment, 2016" provides an overview of Neurological Diagnostic Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Neurological Diagnostic Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Neurological Diagnostic Equipment under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Neurological Diagnostic Equipment and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Neurological Diagnostic Equipment under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Neurological Diagnostic Equipment - Medical Devices Pipeline Assessment, 2016
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 20
2 Introduction 21
2.1 Neurological Diagnostic Equipment Overview 21
3 Products under Development 22
3.1 Neurological Diagnostic Equipment - Pipeline Products by Stage of Development 22
3.2 Neurological Diagnostic Equipment - Pipeline Products by Segment 23
3.3 Neurological Diagnostic Equipment - Pipeline Products by Territory 24
3.4 Neurological Diagnostic Equipment - Pipeline Products by Regulatory Path 25
3.5 Neurological Diagnostic Equipment - Pipeline Products by Estimated Approval Date 26
3.6 Neurological Diagnostic Equipment - Ongoing Clinical Trials 27
4 Neurological Diagnostic Equipment - Pipeline Products under Development by Companies 28
4.1 Neurological Diagnostic Equipment Companies - Pipeline Products by Stage of Development 28
4.2 Neurological Diagnostic Equipment - Pipeline Products by Stage of Development 33
5 Neurological Diagnostic Equipment Companies and Product Overview 38
5.1 Acreo Swedish ICT AB Company Overview 38
5.2 ADM Diagnostics LLC Company Overview 40
5.3 Ad-Tech Medical Instrument Corp Company Overview 41
5.4 Advanced Brain Monitoring Inc Company Overview 42
5.5 Advanced Diamond Technologies, Inc. Company Overview 43
5.6 advanced neurometrics inc. Company Overview 44
5.7 AnthroTronix, Inc. Company Overview 45
5.8 Barron Associates, Inc. Company Overview 48
5.9 Bio-Signal Group Corp. Company Overview 50
5.10 BioSignostix Inc. Company Overview 51
5.11 BiReme Pty Ltd Company Overview 52
5.12 Brain Sentinel Company Overview 53
5.13 BrainCare OY Company Overview 56
5.14 Brainchem, LLC Company Overview 57
5.15 BrainScope Company, Inc. Company Overview 59
5.16 Braintech Ltd. Company Overview 64
5.17 Cambridge Cognition Holdings plc Company Overview 65
5.18 Cerora, Inc. Company Overview 67
5.19 Children's Hospital and Research Center Oakland Company Overview 71
5.20 Cleveland Medical Devices Inc Company Overview 73
5.21 Cognionics, Inc. Company Overview 75
5.22 Cognitive Sensing Inc. Company Overview 76
5.23 Columbia University Medical Center Company Overview 77
5.24 Converge Medical, Inc Company Overview 78
5.25 Cortec GmbH Company Overview 79
5.26 Dartmouth College Company Overview 81
5.27 DMetrix, Inc. Company Overview 82
5.28 Drexel University Company Overview 84
5.29 Ecole Polytechnique de Montreal Company Overview 85
5.30 EIC Laboratories, Inc. Company Overview 86
5.31 Electrical Geodesics, Inc. Company Overview 87
5.32 ElMinda Ltd Company Overview 94
5.33 Epitel, Inc. Company Overview 100
5.34 Exploit Technologies Pte Ltd Company Overview 101
5.35 Flint Hills Scientific LLC Company Overview 103
5.36 HeadSense Medical Ltd. Company Overview 105
5.37 HEARD Medical Company Overview 113
5.38 Henry Ford Health System Company Overview 114
5.39 i360medical Limited Company Overview 116
5.40 IMEC Company Overview 117
5.41 Imperial College London Company Overview 118
5.42 Incereb Medical Ltd. Company Overview 119
5.43 Infinite Biomedical Technologies LLC Company Overview 121
5.44 InfraScan, Inc. Company Overview 123
5.45 Integer Holdings Corporation Company Overview 125
5.46 Integra LifeSciences Holdings Corp Company Overview 127
5.47 Integrated Sensing Systems Inc Company Overview 129
5.48 Jan Medical, Inc. Company Overview 131
5.49 KeepAlive Medical Ltd Company Overview 136
5.50 Koronis Biomedical Technologies Corporation Company Overview 137
5.51 Lara Diagnostics AB Company Overview 138
5.52 Leap Medical Inc. Company Overview 139
5.53 LivaNova PLC Company Overview 140
5.54 Masimo Corp Company Overview 142
5.55 Massachusetts Institute of Technology Company Overview 144
5.56 McGill University Company Overview 145
5.57 Medfield Diagnostics AB Company Overview 147
5.58 Medisens Wireless, Inc. Company Overview 150
5.59 Mindful Scientific Inc. Company Overview 152
5.60 Neba Health, LLC Company Overview 153
5.61 Neural Analytics, Inc. Company Overview 155
5.62 Neural Diagnostics Pty Ltd Company Overview 157
5.63 Neuro Assessment Systems Company Overview 159
5.64 Neuro Devices, Inc. Company Overview 160
5.65 Neuro Kinetics, Inc. Company Overview 161
5.66 NeuroDx Development LLC Company Overview 162
5.67 NeuroInDx, Inc. Company Overview 163
5.68 Neurokeeper Technologies Company Overview 164
5.69 NeuroMetrix Inc Company Overview 165
5.70 NeuroVigil Inc Company Overview 167
5.71 NeuroWave Systems Inc Company Overview 168
5.72 NexGen Medical Systems Inc Company Overview 170
5.73 North Carolina State University Company Overview 171
5.74 Northwestern University Company Overview 172
5.75 NovoView Diagnostics LLC Company Overview 173
5.76 Oculogica Inc. Company Overview 174
5.77 Optima Neuroscience Inc Company Overview 176
5.78 Ornim Inc Company Overview 177
5.79 Orsan Medical Technologies Ltd. Company Overview 180
5.80 QUASAR, Inc. Company Overview 181
5.81 Reach Bionics, Inc. Company Overview 182
5.82 ReHaptix GmbH Company Overview 183
5.83 Remote Vital Monitoring Inc Company Overview 184
5.84 SensoDetect AB Company Overview 185
5.85 Senzime AB Company Overview 187
5.86 SFC Fluidics LLC Company Overview 190
5.87 Simon Fraser University Company Overview 191
5.88 Skulpt Inc Company Overview 192
5.89 Smart Monitor Company Overview 193
5.90 SoNovum AG Company Overview 194
5.91 Southeast TechInventures Inc Company Overview 195
5.92 Spectros Corp Company Overview 196
5.93 Spire Corporation Company Overview 197
5.94 Stanford University Company Overview 199
5.95 Swansea University Company Overview 200
5.96 Tel Aviv Sourasky Medical Center Company Overview 201
5.97 Tel Aviv University Company Overview 202
5.98 The Feinstein Institute for Medical Research Company Overview 203
5.99 The University of Queensland Company Overview 205
5.100 Third Eye Diagnostics, Inc. Company Overview 206
5.101 Tristan Technologies, Inc. Company Overview 208
5.102 University College Cork Company Overview 210
5.103 University of California Berkeley Company Overview 211
5.104 University of California Los Angeles Company Overview 213
5.105 University of California San Diego Company Overview 215
5.106 University of Cambridge Company Overview 217
5.107 University of Cantabria Company Overview 219
5.108 University of Canterbury Company Overview 220
5.109 University of Cincinnati Company Overview 221
5.110 University of Colorado Company Overview 223
5.111 University of Florida Company Overview 226
5.112 University of Hertfordshire Company Overview 228
5.113 University of Illinois Company Overview 229
5.114 University of Michigan Company Overview 230
5.115 University of Pennsylvania Company Overview 233
5.116 University of Texas Health Science Center at Houston Company Overview 235
5.117 VisionQuest Biomedical, LLC Company Overview 237
5.118 Vittamed Corporation Company Overview 239
5.119 Vivonics, Inc. Company Overview 241
5.120 Washington and Lee University Company Overview 243
5.121 Washington University in St Louis Company Overview 244
5.122 Wisconsin Institute of Nuclear Systems Company Overview 245
5.123 York Instruments Ltd Company Overview 247
6 Neurological Diagnostic Equipment- Recent Developments 249
6.1 Dec 01, 2016: Elekta Interim Report May-October 2016/17 249
6.2 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 250
6.3 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 252
6.4 Nov 15, 2016: Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation 253
6.5 Nov 15, 2016: Penumbra Announces Resignation of Board Member 253
6.6 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 254
6.7 Nov 10, 2016: Bittium Technologies Acquires Remega 254
6.8 Nov 08, 2016: Ambu: Annual report 2015/16 254
6.9 Nov 08, 2016: NeuroMetrix Announces Promotion of Frank McGillin to Chief Commercial Officer 255
6.10 Nov 08, 2016: CASMED Reports Third-Quarter 2016 Financial Results 255
6.11 Nov 07, 2016: Senzime to conduct clinical trial at NorthShore in Chicago, USA 257
6.12 Nov 07, 2016: Philips and Masimo Sign Multi-Year Business Partnership Agreement in Patient Monitoring and Select Therapy Solutions 257
6.13 Nov 03, 2016: Penumbra Reports Third Quarter 2016 Financial Results 258
6.14 Nov 02, 2016: Masimo Reports Third Quarter 2016 Financial Results 259
6.15 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 259
6.16 Oct 27, 2016: Adam Mikkelson of Camber Capital Management Joins Masimo's Board of Directors 260
6.17 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 260
6.18 Oct 20, 2016: NeuroMetrix Reports Q3 2016 Financial Results 261
6.19 Oct 19, 2016: Natus Medical Announces Third Quarter 2016 Financial Results 262
6.20 Oct 18, 2016: Curelator Headache announces study with NYU Langone Medical Center to examine effectiveness of protective behaviors for migraineurs and post-concussive headache patients 264
6.21 Oct 12, 2016: Neural Analytics Announces First Patient Enrolled in EXPEDITE Study at Erlanger; To Evaluate Next Generation Portable Diagnostic Platform for Early Detection of Stroke 264
6.22 Oct 05, 2016: Henry Ford Health System Announces New CEO of Health Alliance Plan 265
6.23 Sep 29, 2016: Croton Healthcare Canada, York Instruments and Simon Fraser University Undertake Clinical Study Of MEG Effectiveness In Diagnosing Brain Concussions 266
6.24 Sep 26, 2016: BrainScope Announces FDA Clearance of the First Handheld Medical Device for Assessment of the Full Spectrum of Traumatic Brain Injury 266
6.25 Sep 22, 2016: Cambridge Cognition Holdings: Half Yearly Report 267
6.26 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 268
6.27 Sep 14, 2016: Neural Analytics Receives $3 Million NIH Grant to Develop Brain Diagnostic and Monitoring Technologies to Accelerate Detection of Traumatic Brain Injury and Stroke 269
6.28 Sep 12, 2016: Neurotech International Raises USD5.3 Million in IPO of Shares 269
6.29 Sep 01, 2016: Elekta: Interim Report May - July 2016/17 269
6.30 Aug 31, 2016: Scientists discover non-invasive technique to monitor migraines 270
6.31 Aug 29, 2016: Electrical Geodesics Announces Six Month Period of Strong Revenue Growth 271
6.32 Aug 26, 2016: Electrical Geodesics Announces A Period of Strong Revenue Growth 272
6.33 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 272
6.34 Aug 19, 2016: Ambu: Interim report for Q3 2015/16 275
6.35 Aug 09, 2016: Abrazo Arizona Heart Hospital Selects SafeOp Neuromonitoring Technology 275
6.36 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results 276
6.37 Aug 04, 2016: CASMED Reports Second-Quarter 2016 Financial Results 276
6.38 Aug 03, 2016: Masimo Reports Second Quarter 2016 Financial Results 278
7 Appendix 309
7.1 Methodology 309
7.2 About GlobalData 312
7.3 Contact Us 312
7.4 Disclaimer 312

1.1 List of Tables
Table 1: Neurological Diagnostic Equipment - Pipeline Products by Stage of Development 25
Table 2: Neurological Diagnostic Equipment - Pipeline Products by Segment 26
Table 3: Neurological Diagnostic Equipment - Pipeline Products by Territory 27
Table 4: Neurological Diagnostic Equipment - Pipeline Products by Regulatory Path 28
Table 5: Neurological Diagnostic Equipment - Pipeline Products by Estimated Approval Date 29
Table 6: Neurological Diagnostic Equipment - Ongoing Clinical Trials 30
Table 7: Neurological Diagnostic Equipment Companies - Pipeline Products by Stage of Development 31
Table 8: Neurological Diagnostic Equipment - Pipeline Products by Stage of Development 36
Table 9: Acreo Swedish ICT AB Pipeline Products and Ongoing Clinical Trials Overview 41
Table 10: IDM21 - Product Status 41
Table 11: IDM21 - Product Description 42
Table 12: ADM Diagnostics LLC Pipeline Products and Ongoing Clinical Trials Overview 43
Table 13: ADMdx - Alzheimer's Disease - Product Status 43
Table 14: ADMdx - Alzheimer's Disease - Product Description 43
Table 15: Ad-Tech Medical Instrument Corp Pipeline Products and Ongoing Clinical Trials Overview 44
Table 16: ICP Monitor - Product Status 44
Table 17: ICP Monitor - Product Description 44
Table 18: Advanced Brain Monitoring Inc Pipeline Products and Ongoing Clinical Trials Overview 45
Table 19: B-Alert X24 System - Product Status 45
Table 20: B-Alert X24 System - Product Description 45
Table 21: Advanced Diamond Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 46
Table 22: Chronically Implantable UNCD Microarray Electrode - Product Status 46
Table 23: Chronically Implantable UNCD Microarray Electrode - Product Description 46
Table 24: advanced neurometrics inc. Pipeline Products and Ongoing Clinical Trials Overview 47
Table 25: ANI-SI EEG System - Product Status 47
Table 26: ANI-SI EEG System - Product Description 47
Table 27: AnthroTronix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 48
Table 28: DANA - Product Status 48
Table 29: DANA - Product Description 48
Table 30: AnthroTronix, Inc. - Ongoing Clinical Trials Overview 49
Table 31: DANA - Caregivers Virtual Health eBrain Study II 49
Table 32: DANA - Phase II Health-eBrain Study to Analyzes Cognitive and Emotional Health of Caregivers of Alzheimer's Patients 50
Table 33: Barron Associates, Inc. Pipeline Products and Ongoing Clinical Trials Overview 51
Table 34: DASSO - Product Status 51
Table 35: DASSO - Product Description 51
Table 36: GEMINI System - Product Status 52
Table 37: GEMINI System - Product Description 52
Table 38: Bio-Signal Group Corp. Pipeline Products and Ongoing Clinical Trials Overview 53
Table 39: Wireless MicroEEG - Neonatal Apnea - Product Status 53
Table 40: Wireless MicroEEG - Neonatal Apnea - Product Description 53
Table 41: BioSignostix Inc. Pipeline Products and Ongoing Clinical Trials Overview 54
Table 42: Neurosomex - Product Status 54
Table 43: Neurosomex - Product Description 54
Table 44: BiReme Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview 55
Table 45: BRtest - Product Status 55
Table 46: BRtest - Product Description 55
Table 47: Brain Sentinel Pipeline Products and Ongoing Clinical Trials Overview 56
Table 48: Brain Sentinel - Product Status 56
Table 49: Brain Sentinel - Product Description 56
Table 50: Brain Sentinel - Ongoing Clinical Trials Overview 57
Table 51: Brain Sentinel - A Health Economic Study Evaluating the Brain Sentinel GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization 57
Table 52: Brain Sentinel - A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures with a Seizure Detection and Warning System (System Version 1.5) in Epilepsy Patients 58
Table 53: Brain Sentinel - A Pivotal, Phase III Trial of Detecting Generalized Tonic-clonic Seizures with a Seizure Detection and Warning System in Epilepsy Patients 58
Table 54: Brain Sentinel - A Pivotal, Phase III Trial of Detecting Generalized Tonic-clonic Seizures with a Seizure Detection and Warning System in Epilepsy Patients 58
Table 55: BrainCare OY Pipeline Products and Ongoing Clinical Trials Overview 59
Table 56: EEG Implant - Product Status 59
Table 57: EEG Implant - Product Description 59
Table 58: Brainchem, LLC Pipeline Products and Ongoing Clinical Trials Overview 60
Table 59: Intra-Operative Neuro-Monitoring Device - Epilepsy - Product Status 60
Table 60: Intra-Operative Neuro-Monitoring Device - Epilepsy - Product Description 60
Table 61: Intra-Operative Neuro-Monitoring Device - Traumatic Brain Injury - Product Status 61
Table 62: Intra-Operative Neuro-Monitoring Device - Traumatic Brain Injury - Product Description 61
Table 63: BrainScope Company, Inc. Pipeline Products and Ongoing Clinical Trials Overview 62
Table 64: BrainScope Device - Alzheimer's Disease - Product Status 62
Table 65: BrainScope Device - Alzheimer's Disease - Product Description 63
Table 66: BrainScope Device - Depression - Product Status 63
Table 67: BrainScope Device - Depression - Product Description 63
Table 68: BrainScope Device - Seizure - Product Status 64
Table 69: BrainScope Device - Seizure - Product Description 64
Table 70: BrainScope Device - Stroke - Product Status 64
Table 71: BrainScope Device - Stroke - Product Description 65
Table 72: BrainScope NT-1000 - Product Status 65
Table 73: BrainScope NT-1000 - Product Description 65
Table 74: BrainScope Company, Inc. - Ongoing Clinical Trials Overview 66
Table 75: BrainScope NT-1000 - Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization 66
Table 76: Braintech Ltd. Pipeline Products and Ongoing Clinical Trials Overview 67
Table 77: BrainTech Mental Disorders Diagnosis - Product Status 67
Table 78: BrainTech Mental Disorders Diagnosis - Product Description 67
Table 79: Cambridge Cognition Holdings plc Pipeline Products and Ongoing Clinical Trials Overview 68
Table 80: CANTAB Mobile - Product Status 68
Table 81: CANTAB Mobile - Product Description 69
Table 82: Cerora, Inc. Pipeline Products and Ongoing Clinical Trials Overview 70
Table 83: Cerora Borealis - Product Status 70
Table 84: Cerora Borealis - Product Description 71
Table 85: MindReader - Product Status 71
Table 86: MindReader - Product Description 72
Table 87: MindReader - Autism - Product Status 72
Table 88: MindReader - Autism - Product Description 72
Table 89: MindReader - Neurodegenerative Conditions - Product Status 73
Table 90: MindReader - Neurodegenerative Conditions - Product Description 73
Table 91: Children's Hospital and Research Center Oakland Pipeline Products and Ongoing Clinical Trials Overview 74
Table 92: Eye-Com Biosensor - Product Status 74
Table 93: Eye-Com Biosensor - Product Description 75
Table 94: Cleveland Medical Devices Inc Pipeline Products and Ongoing Clinical Trials Overview 76
Table 95: Electroencephalogram Electrode - Product Status 76
Table 96: Electroencephalogram Electrode - Product Description 77
Table 97: Cognionics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 78
Table 98: EEG Headset System - Product Status 78
Table 99: EEG Headset System - Product Description 78
Table 100: Cognitive Sensing Inc. Pipeline Products and Ongoing Clinical Trials Overview 79
Table 101: NeuroMinder MPI Early Detection Device - Product Status 79
Table 102: NeuroMinder MPI Early Detection Device - Product Description 79
Table 103: Columbia University Medical Center Pipeline Products and Ongoing Clinical Trials Overview 80
Table 104: Online Intracranial EEG Acquisition System - Product Status 80
Table 105: Online Intracranial EEG Acquisition System - Product Description 80
Table 106: Converge Medical, Inc Pipeline Products and Ongoing Clinical Trials Overview 81
Table 107: Brain Function Monitor - Product Status 81
Table 108: Brain Function Monitor - Product Description 81
Table 109: Cortec GmbH Pipeline Products and Ongoing Clinical Trials Overview 82
Table 110: AirRay - Product Status 82
Table 111: AirRay - Product Description 83
Table 112: Dartmouth College Pipeline Products and Ongoing Clinical Trials Overview 84
Table 113: Analog-To-Digital Converter (ADC) Device - Product Status 84
Table 114: Analog-To-Digital Converter (ADC) Device - Product Description 84
Table 115: DMetrix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 85
Table 116: V6 - Product Status 85
Table 117: V6 - Product Description 86
Table 118: Drexel University Pipeline Products and Ongoing Clinical Trials Overview 87
Table 119: Chronic Intraspinal Multielectrode Probe - Product Status 87
Table 120: Chronic Intraspinal Multielectrode Probe - Product Description 87
Table 121: Ecole Polytechnique de Montreal Pipeline Products and Ongoing Clinical Trials Overview 88
Table 122: EMGdi Filtering System - Product Status 88
Table 123: EMGdi Filtering System - Product Description 88
Table 124: EIC Laboratories, Inc. Pipeline Products and Ongoing Clinical Trials Overview 89
Table 125: Wireless EcoG Recording System - Epilepsy - Product Status 89
Table 126: Wireless EcoG Recording System - Epilepsy - Product Description 89
Table 127: Electrical Geodesics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 90
Table 128: Brain Bleeding Monitor - Product Status 90
Table 129: Brain Bleeding Monitor - Product Description 91
Table 130: dEEG/NIRS System - Infants - Product Status 91
Table 131: dEEG/NIRS System - Infants - Product Description 92
Table 132: Dense Array EEG - Product Status 92
Table 133: Dense Array EEG - Product Description 93
Table 134: EEG Ink Net - Product Status 93
Table 135: EEG Ink Net - Product Description 94
Table 136: Electrical Geodesics, Inc. - Ongoing Clinical Trials Overview 95
Table 137: Dense Array EEG - New Approaches for the Diagnosis of Alzeimer's Disease Through Neuroelectrical Changes in the Brain 96
Table 138: ElMinda Ltd Pipeline Products and Ongoing Clinical Trials Overview 97
Table 139: BNA Platform - ADHD - Product Status 97
Table 140: BNA Platform - ADHD - Product Description 98
Table 141: BNA Platform - Alzheimer's Disease - Product Status 98
Table 142: BNA Platform - Alzheimer's Disease - Product Description 99
Table 143: BNA Platform - Migraine - Product Status 99
Table 144: BNA Platform - Migraine - Product Description 99
Table 145: BNA Platform - Mood Disorder - Product Status 100
Table 146: BNA Platform - Mood Disorder - Product Description 100
Table 147: BNA Platform - Pain - Product Status 101
Table 148: BNA Platform - Pain - Product Description 101
Table 149: BNA Platform - Parkinson's Disease - Product Status 101
Table 150: BNA Platform - Parkinson's Disease - Product Description 102
Table 151: Epitel, Inc. Pipeline Products and Ongoing Clinical Trials Overview 103
Table 152: Wireless EEG Seizure Patch - Product Status 103
Table 153: Wireless EEG Seizure Patch - Product Description 103
Table 154: Exploit Technologies Pte Ltd Pipeline Products and Ongoing Clinical Trials Overview 104
Table 155: StrokeCAD - Product Status 104
Table 156: StrokeCAD - Product Description 105
Table 157: Flint Hills Scientific LLC Pipeline Products and Ongoing Clinical Trials Overview 106
Table 158: Seizure Detection Device - Product Status 106
Table 159: Seizure Detection Device - Product Description 107
Table 160: HeadSense Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 108

1.2 List of Figures
Figure 1: Neurological Diagnostic Equipment - Pipeline Products by Stage of Development 25
Figure 2: Neurological Diagnostic Equipment - Pipeline Products by Segment 26
Figure 3: Neurological Diagnostic Equipment - Pipeline Products by Territory 27
Figure 4: Neurological Diagnostic Equipment - Pipeline Products by Regulatory Path 28
Figure 5: Neurological Diagnostic Equipment - Pipeline Products by Estimated Approval Date 29
Figure 6: Neurological Diagnostic Equipment - Ongoing Clinical Trials 30

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Proteomics Market by Instrument, Reagent & Service, Application - Forecast to 2021

Proteomics Market by Instrument, Reagent & Service, Application - Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global proteomics market is projected to reach USD 21.87 billion by 2021, at a CAGR of 11.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising acceptance ...

High-Throughput Screening Market by Technology, Application, Product, End User - Forecast to 2021

High-Throughput Screening Market by Technology, Application, Product, End User - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The high-throughput screening (HTS) market is expected to grow at a lucrative CAGR of 7.8% from 2016 to 2021, to reach USD 18.83 billion by 2021 from USD 12.23 billion in 2016. Market growth can be attributed ...

Global Protein Expression Market

December 2016 $ 4250

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.